New Program for Brain Cancer Research
April 10, 2025 – The Cancer Research Society (CRS), in partnership with Brain Canada and the Kindred Foundation, announces the launch of a national program to fund translational brain cancer research. This program is supported by an exceptional investment of $2 million.
A Complex Disease Still Difficult to Treat
Every day, eight Canadians are diagnosed with brain cancer. This cancer, particularly prevalent among children, remains one of the most complex and difficult to treat. Despite existing options, treatments are still limited, and the diversity of brain tumors makes progress even more challenging. This new program aims to accelerate the application of scientific discoveries to address these challenges.
Accelerating Research to Make a Difference
This initiative aims to foster multidisciplinary collaborations between researchers and clinicians to find new approaches for studying, diagnosing, or treating brain cancer in children and/or adults.
Supported projects must propose innovative approaches to:
- Better understand the mechanisms underlying brain cancer
- Develop or test new technologies, including artificial intelligence, to improve diagnosis and treatments
- Apply innovative solutions to target brain tumors at all stages: primary, metastatic, and recurrent
- Develop or refine precision medicine solutions to make better treatment decisions for patients
Two projects will receive $1 million in funding each, over a three-year period. An additional grant may also be awarded for a project focusing on low-grade diffuse glioma in children or young adults.
This partnership reflects a shared commitment from our three organizations to research and innovation. Together, we have the power to outsmart brain cancer and bring new hope to all those affected by this disease.
Researchers interested in this opportunity are invited to consult the complete program details: here.
Thanks to our partners
